APD597 from MedChemExpress

APD597 (JNJ-38431055) is an orally active agonist of GPR119. APD597 exhibits reduced CYP2C9 inhibition with an IC50 of 5.8 µM. APD597 can be studied in research for type 2 diabetes[1][2][3]